Suppr超能文献

用于检测扩增产物残留的特异性引物的设计与应用。

Design and use of signature primers to detect carry-over of amplified material.

作者信息

Abbott L Z, Spicer T, Bryz-Gornia V, Kwok S, Sninsky J, Poiesz B

机构信息

Department of Medicine, SUNY Health Science Center, Syracuse 13210.

出版信息

J Virol Methods. 1994 Jan;46(1):51-9. doi: 10.1016/0166-0934(94)90016-7.

Abstract

Signature primer pairs designed for use with the polymerase chain reaction have been developed which can determine if a positive result originated from the intended target nucleic acid or from so-called "carry-over" contamination of previously amplified DNA. The 3' ends of each signature primer, SK339/341, SSK110/111, and SSK58/59 contain a viral specific sequence complementary to regions of either HIV-1, HTLV-I and II respectively. The 5' ends of each primer contain a non-human, non-viral (NHNV) signature sequence including restriction endonuclease sites for subsequent cloning. A fourth set of primers, SK338/340, consist solely of these NHNV sequences and are designed to anneal to any product previously amplified by the viral-specific signature primers. These primers were tested against their corresponding positive and negative DNA targets, to determine their specificity and sensitivity. As expected, the viral-specific signature primers detected the retroviral infected samples while no detectable amplification occurred in negative DNA controls. Primers SK338/340 did not amplify any viral positive or negative template DNA's. Samples spiked with amplified material generated from the viral-specific signature primers could be specifically amplified by the NHNV primers SK338/340. Primers SK338/340 were determined to be more sensitive than the viral-specific signature primers, ensuring the detection of extremely low amounts of carryover. This strategy may be useful in developing other retroviral or non-retroviral primers with a built-in signature sequence that can differentiate false positives from true positives in a subsequent confirmatory test.

摘要

已开发出用于聚合酶链反应的特异性引物对,可确定阳性结果是源自预期的靶核酸,还是源自先前扩增的DNA的所谓“残留”污染。每个特异性引物SK339/341、SSK110/111和SSK58/59的3'端分别包含与HIV-1、HTLV-I和II区域互补的病毒特异性序列。每个引物的5'端包含非人类、非病毒(NHNV)特异性序列,包括用于后续克隆的限制性内切酶位点。第四组引物SK338/340仅由这些NHNV序列组成,旨在与先前由病毒特异性引物扩增的任何产物退火。针对相应的阳性和阴性DNA靶标对这些引物进行了测试,以确定其特异性和敏感性。正如预期的那样,病毒特异性引物检测到了逆转录病毒感染的样本,而在阴性DNA对照中未发生可检测到的扩增。引物SK338/340未扩增任何病毒阳性或阴性模板DNA。用病毒特异性引物产生的扩增材料加标的样本可被NHNV引物SK338/340特异性扩增。已确定引物SK338/340比病毒特异性引物更敏感,可确保检测到极低量的残留。该策略可能有助于开发其他具有内置特异性序列的逆转录病毒或非逆转录病毒引物,以便在后续确证试验中区分假阳性和真阳性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验